A Efficacy and Safety Study of R935788 in the Treatment of Persistent/Chronic Immune Thrombocytopenic Purpura (ITP)

PHASE3CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

July 14, 2014

Primary Completion Date

April 21, 2016

Study Completion Date

April 21, 2016

Conditions
Immune Thrombocytopenic Purpura
Interventions
DRUG

Fostamatinib disodium

Fostamatinib (100 mg PO bid or 150 mg PO bid)

DRUG

Placebo

Placebo tablet PO bid (morning and evening) over the course of 24 weeks

Trial Locations (52)

2031

Prince of Wales Hospital, Randwick

2139

Concord Repatriation General Hospital, Concord

2145

Westmead Hospital, Westmead

2170

Liverpool Hospital, Liverpool

2217

St George Hospital, Kogarah

2730

Herlev Hospital University of Copenhagen, Department of Hematology L124, Herlev

3004

Dept of Haematology, The Alfred Hospital and Monash Medical Centre, Melbourne

3199

Frankston Hospital, Frankston

4000

Hematological department, Roskilde Hospital, Roskilde

6009

Perth Blood Institute, Nedlands

7250

Launceston General Hospital, Launceston

9000

Aarhus University Hospital, Aalborg

10065

Weill Cornell Medical College/New York Presbyterian Hospital, New York

20132

Ospedale San Raffaele S.r.l. Dipartimento di Oncoematologia, Milan

20817

Center for Cancer and Blood Disorders, Bethesda

22908

University of Virginia, Charlottesville

27858

Pitt County Memorial Hospital, Greenville

28144

Bill Hefner VA Medical Center, Salisbury

33100

OspedaleCivile-ClinicaEmatologica/PUGD, Udine

40138

Ematologia - Padigilione 8, Policinico S. Orsola Malpighi, Azienda Ospedaliero Universitaria di Bologna, Bologna

44195

Cleveland Clinic, Cleveland

45042

Signal Point Clinical Research Center LLC, Middletown

47905

Horizon Oncology Research, Inc, Lafayette

61614

Bleeding & Clotting Disorders Institute, Peoria

80131

Universitã Federico II di Napoli, Napoli

84132

University of Utah Health Sciences Center, Salt Lake City

85710

Arizona Oncology Associates, Tucson

90089

University of Southern California, Los Angeles

33805-1965

Lakeland Regional Cancer Center, Lakeland

L8N 3Z5

Hamilton Health Sciences Corporation, Hamilton

K1 H8L6

Ottawa Hospital Research Institute, Ottawa

M5B1W8

St. Michael's Hospital, Toronto

DK-5000

Dept. of Haematology, Odense University Hospital, Odense C

H-1083

Semmelweis University 1st, Budapest

University of Debrecen, Debrecen

H-7624

Pecs University, Pécs

Unknown

ULSS 6 Vicenza-Ospedale San Bortolo di Vicenza, Vicenza

2545 CH

HAGA ziekenhuis, Haag

CT1 3NG

Kent & Canterbury Hospital, Kent

CO4 5JL

Colchester General Hospital, Colchester

L78XP

Royal Liverpool University Hospital, Liverpool

LS9 7TF

St. James's Hospital, Leeds

LE1 5WW

Leicester Royal Infirmary, Leicester

E1 2ES

Royal London Hospital, London

W12 0HS

Hammersmith Hospital, Catherine Lewis Centre, London

WC1E 6HX

University College Hospital, London

M139WL

Manchester Royal Infirmary, Manchester

NE1 4LP

Royal Victoria Infirmary, Newcastle upon Tyne

NR31 6LA

James Paget University Hospital, Norfolk

OX3 9BQ

Oxford University Hospital, Oxford

ST4 6QG

University Hospital of North Staffordshire, Stoke-on-Trent

B71 4HJ

Sandwell General Hospital, West Bromwich

Sponsors
All Listed Sponsors
lead

Rigel Pharmaceuticals

INDUSTRY